Learn
Straightforward articles to help you make informed decisions about GLP-1 treatments.
After fake pens were seized in Haryana, Lilly started sending patients side-by-side images of real and counterfeit packaging. Six batch numbers have now been declared spurious.
Read articleLilly's free verification tool checks Mounjaro serial numbers against their database. But if you bought your injection in India, it won't help you.
Read articlePeptides from Alibaba, packaging from a 3D printer, recipes from YouTube. That's how counterfeit Mounjaro was being manufactured in a rented apartment.
Read articleWhen semaglutide went generic, 40+ manufacturers launched overnight. In a country where a third of drug samples from Delhi's largest pharma market test as counterfeit, that's a problem.
Read articleJitendra Chouksey asked CDSCO for the clinical trial data behind India's generic GLP-1 approvals. They refused. So he filed a PIL, and then a contempt petition.
Read articleA practical look at the two most-studied GLP-1 options, how they compare, and why patience in the early weeks matters more than most people expect.
Read articleA plain-language primer on how GLP-1 receptor agonists work, who they're for, and what to expect.
Read articlePractical, patient-tested tips for handling nausea, fatigue, and other early-stage side effects.
Read article